ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P22055


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name POLG_CXA21
Primary accession number P22055
Secondary accession numbers None
Integrated into Swiss-Prot on August 1, 1991
Sequence was last modified on January 23, 2007 (Sequence version 3)
Annotations were last modified on    November 25, 2008 (Entry version 88)
Name and origin of the protein
Protein name Genome polyprotein
Synonyms None
Contains Protein VP0
     (VP4-VP2)
Protein VP4
     (Virion protein 4)
     (P1A)
Protein VP2
     (Virion protein 2)
     (P1B)
Protein VP3
     (Virion protein 3)
     (P1C)
Protein VP1
     (Virion protein 1)
     (P1D)
Picornain 2A
     (Protein 2A)
     (P2A)
     (EC 3.4.22.29)
Protein 2B
     (P2B)
Protein 2C
     (P2C)
     (EC 3.6.1.15)
Protein 3A
     (P3A)
Protein 3B
     (P3B)
     (VPg)
Picornain 3C
     (EC 3.4.22.28)
     (Protease 3C)
     (P3C)
RNA-directed RNA polymerase 3D-POL
     (P3D-POL)
     (EC 2.7.7.48)
Gene name None
From
Coxsackievirus A21 (strain Coe) [TaxID: 12070] 
Taxonomy Viruses; ssRNA positive-strand viruses, no DNA stage; Picornavirales; Picornaviridae; Enterovirus.
Virus host Homo sapiens (Human) [TaxID: 9606]
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [GENOMIC RNA].
PubMed=2584950 [NCBI, ExPASy, EBI, Israel, Japan]
Hughes P.J., North C., Minor P.D., Stanway G.;
"The complete nucleotide sequence of coxsackievirus A21.";
J. Gen. Virol. 70:2943-2952(1989).
Comments
  • FUNCTION: Capsid proteins VP1, VP2, VP3 and VP4 form a closed capsid enclosing the viral positive strand RNA genome. VP4 lies on the inner surface of the protein shell formed by VP1, VP2 and VP3. All the three latter proteins contain a beta-sheet structure called beta-barrel jelly roll. Together they form an icosahedral capsid (T=3) composed of 60 copies of each VP1, VP2, and VP3, with a diameter of approximately 300 Angstroms. VP1 is situated at the 12 fivefold axes, whereas VP2 and VP3 are located at the quasi-sixfold axes. The capsid interacts with human ICAM1 to provide virion attachment to target cell (By similarity).
  • FUNCTION: VP0 precursor is a component of immature procapsids (By similarity).
  • FUNCTION: Protein 2A is a cysteine protease that is responsible for the cleavage between the P1 and P2 regions. It cleaves the host translation initiation factor EIF4G1, in order to shut down the capped cellular mRNA transcription (By similarity).
  • FUNCTION: Protein 2B affects membrane integrity and cause an increase in membrane permeability (By similarity).
  • FUNCTION: Protein 2C associates with and induces structural rearrangements of intracellular membranes. It displays RNA-binding, nucleotide binding and NTPase activities (By similarity).
  • FUNCTION: Protein 3A, via its hydrophobic domain, serves as membrane anchor. It also inhibits endoplasmic reticulum-to-Golgi transport (By similarity).
  • FUNCTION: Protein 3C is a cysteine protease that generates mature viral proteins from the precursor polyprotein. In addition to its proteolytic activity, it binds to viral RNA, and thus influences viral genome replication. RNA and substrate bind co-operatively to the protease (By similarity).
  • FUNCTION: RNA-directed RNA polymerase 3D-POL replicates genomic and antigenomic RNA by recognizing replications specific signals (By similarity).
  • CATALYTIC ACTIVITY: Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1).
  • CATALYTIC ACTIVITY: Selective cleavage of Tyr-|-Gly bond in the picornavirus polyprotein.
  • CATALYTIC ACTIVITY: Selective cleavage of Gln-|-Gly bond in the poliovirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly.
  • CATALYTIC ACTIVITY: NTP + H2O = NDP + phosphate.
  • SUBCELLULAR LOCATION: Protein VP2: Virion. Cytoplasm (Potential).
  • SUBCELLULAR LOCATION: Protein VP3: Virion. Cytoplasm (Potential).
  • SUBCELLULAR LOCATION: Protein VP1: Virion. Cytoplasm (Potential).
  • SUBCELLULAR LOCATION: Protein 2B: Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side (Potential). Note=Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum (By similarity).
  • SUBCELLULAR LOCATION: Protein 2C: Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side (Potential). Note=Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum (By similarity).
  • SUBCELLULAR LOCATION: Protein 3A: Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side (Potential). Note=Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum (By similarity).
  • SUBCELLULAR LOCATION: Protein 3B: Virion (Potential).
  • SUBCELLULAR LOCATION: Picornain 3C: Cytoplasm (Potential).
  • SUBCELLULAR LOCATION: RNA-directed RNA polymerase 3D-POL: Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side (Potential). Note=Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum (By similarity).
  • PTM: Specific enzymatic cleavages in vivo by the viral proteases yield a variety of precursors and mature proteins. Polyprotein processing intermediates such as VP0 which is a VP4-VP2 precursor are produced. During virion maturation, non-infectious particles are rendered infectious following cleavage of VP0. This maturation cleavage is followed by a conformational change of the particle (By similarity).
  • PTM: VPg is covalently linked to the genomic RNA (By similarity).
  • PTM: Myristoylation of VP4 is required during RNA encapsidation and formation of the mature virus particle (By similarity).
  • SIMILARITY: Belongs to the picornaviruses polyprotein family.
  • SIMILARITY: Contains 2 peptidase C3 domains [view classification].
  • SIMILARITY: Contains 1 RdRp catalytic domain.
  • SIMILARITY: Contains 1 SF3 helicase domain.
  • WEB RESOURCE: Name=Virus Particle ExploreR db; Note= Icosahedral capsid structure; URL="http://viperdb.scripps.edu/info_page.php?VDB=1z7s";.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
D00538; BAA00426.1; -; Genomic_RNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR A33373; GNNY21.
RefSeq NP_040759.1; -.
3D structure databases
PDB
1Z7S; X-ray; 3.20 A; 2/3=-, 4=2-69.[ExPASy / RCSB / EBI]
PDBsum 1Z7S; -.
ModBase P22055.
Protein family/group databases
MEROPS C03.001; -.
C03.020; -.
Ontologies
GO
GO:0031410; Cellular component: cytoplasmic vesicle (inferred from electronic annotation from UniProtKB-KW).
GO:0016020; Cellular component: membrane (inferred from electronic annotation from UniProtKB-KW).
GO:0019028; Cellular component: viral capsid (inferred from electronic annotation from InterPro).
GO:0005524; Molecular function: ATP binding (inferred from electronic annotation from UniProtKB-KW).
GO:0004197; Molecular function: cysteine-type endopeptidase activity (inferred from electronic annotation from InterPro).
GO:0003723; Molecular function: RNA binding (inferred from electronic annotation from InterPro).
GO:0003724; Molecular function: RNA helicase activity (inferred from electronic annotation from InterPro).
GO:0003968; Molecular function: RNA-directed RNA polymerase activity (inferred from electronic annotation from InterPro).
GO:0005198; Molecular function: structural molecule activity (inferred from electronic annotation from InterPro).
GO:0044419; Biological process: interspecies interaction between organisms (inferred from electronic annotation from UniProtKB-KW).
GO:0006508; Biological process: proteolysis (inferred from electronic annotation from InterPro).
GO:0018144; Biological process: RNA-protein covalent cross-linking (inferred from electronic annotation from InterPro).
GO:0006410; Biological process: transcription, RNA-dependent (inferred from electronic annotation from InterPro).
GO:0019079; Biological process: viral genome replication (inferred from electronic annotation from InterPro).
QuickGo view.
Family and domain databases
InterPro IPR000605; Helicase_SF3_ssDNA/RNA_vir.
IPR014759; Helicase_SF3_ssRNA_vir.
IPR014838; P3A.
IPR000199; Pept_C3_picorn.
IPR000081; Peptidase_C3.
IPR003138; Pico_P1A.
IPR002527; Pico_P2B.
IPR001676; Picornavirus_capsid.
IPR001205; RNA_pol_P3D.
IPR007094; RNA_pol_PSvir.
Graphical view of domain structure.
Pfam PF08727; P3A; 1.
PF00548; Peptidase_C3; 1.
PF02226; Pico_P1A; 1.
PF00947; Pico_P2A; 1.
PF01552; Pico_P2B; 1.
PF00680; RdRP_1; 1.
PF00073; Rhv; 3.
PF00910; RNA_helicase; 1.
Pfam graphical view of domain structure.
ProDom PD001125; Pept_C3_picorn; 1.
PD001306; Peptidase_C3_2; 1.
PD001274; Pico_P2B; 1.
[Domain structure / List of seq. sharing at least 1 domain]
PROSITE PS50507; RDRP_SSRNA_POS; 1.
PS51218; SF3_HELICASE_2; 1.
PROSITE graphical view of domain structure (profiles).
ProtoNet P22055.
Genome annotation databases
GeneID 1461116; -.
Other
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; ATP-binding; Capsid protein; Complete proteome; Covalent protein-RNA linkage; Cytoplasm; Cytoplasmic vesicle; Helicase; Host-virus interaction; Hydrolase; Lipoprotein; Membrane; Myristate; Nucleotide-binding; Nucleotidyltransferase; Phosphoprotein; Protease; RNA replication; RNA-binding; RNA-directed RNA polymerase; Thiol protease; Transferase; Virion.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom    To Length Description FTId
INIT_MET   1      1        Removed; by host (By similarity). 
CHAIN   2    341  340     Protein VP0 (Potential). PRO_0000311043
CHAIN   2     69  68     Protein VP4 (Potential). PRO_0000039536
CHAIN   70    341  272     Protein VP2 (Potential). PRO_0000039537
CHAIN   342    581  240     Protein VP3 (Potential). PRO_0000039538
CHAIN   582    879  298     Protein VP1 (Potential). PRO_0000039539
CHAIN   880   1028  149     Picornain 2A (Potential). PRO_0000039540
CHAIN   1029   1125  97     Protein 2B (Potential). PRO_0000039541
CHAIN   1126   1453  328     Protein 2C (Potential). PRO_0000039542
CHAIN   1454   1540  87     Protein 3A (Potential). PRO_0000039543
CHAIN   1541   1562  22     Protein 3B (Potential). PRO_0000039544
CHAIN   1563   1745  183     Picornain 3C (Potential). PRO_0000039545
CHAIN   1746   2206  461     RNA-directed RNA polymerase 3D-POL (Potential). PRO_0000039546
TOPO_DOM   2   1517  1516     Cytoplasmic (Potential). 
TOPO_DOM   1518   1533  16     In membrane (Potential). 
TOPO_DOM   1534   2206  673     Cytoplasmic (Potential). 
DOMAIN   1230   1385  156     SF3 helicase. 
DOMAIN   1972   2087  116     RdRp catalytic. 
NP_BIND   1254   1261  8     ATP (Potential). 
ACT_SITE   899    899        For picornain 2A activity (By similarity). 
ACT_SITE   917    917        For picornain 2A activity (By similarity). 
ACT_SITE   988    988        For picornain 2A activity (By similarity). 
ACT_SITE   1602   1602        For picornain 3C activity (Potential). 
ACT_SITE   1633   1633        For picornain 3C activity (Potential). 
ACT_SITE   1709   1709        For picornain 3C activity (By similarity). 
SITE   69     70  2     Cleavage (Potential). 
SITE   341    342  2     Cleavage; by picornain 3C (Potential). 
SITE   879    880  2     Cleavage; by picornain 2A (Potential). 
SITE   1028   1029  2     Cleavage; by picornain 3C (Potential). 
SITE   1125   1126  2     Cleavage; by picornain 3C (Potential). 
SITE   1453   1454  2     Cleavage; by picornain 3C (Potential). 
SITE   1540   1541  2     Cleavage; by picornain 3C (Potential). 
SITE   1562   1563  2     Cleavage; by picornain 3C (Potential). 
SITE   1745   1746  2     Cleavage; by picornain 3C (Potential). 
MOD_RES   1543   1543        O-(5'-phospho-RNA)-tyrosine (By similarity). 
LIPID   2      2        N-myristoyl glycine; by host (By similarity). 
STRAND   4      7  4      
STRAND   26     29  4      
STRAND   33     35  3      
HELIX   36     38  3      
HELIX   51     54  4      
STRAND   57     59  3      
STRAND   83     87  5      
STRAND   90     96  7      
HELIX   103    105  3      
TURN   113    115  3      
HELIX   126    128  3      
STRAND   138    141  4      
STRAND   147    151  5      
HELIX   153    155  3      
HELIX   159    167  9      
STRAND   168    180  13      
STRAND   187    198  12      
STRAND   208    210  3      
HELIX   214    217  4      
HELIX   220    222  3      
HELIX   237    240  4      
STRAND   241    243  3      
HELIX   247    249  3      
TURN   250    252  3      
HELIX   256    261  6      
STRAND   262    268  7      
TURN   269    271  3      
STRAND   273    279  7      
STRAND   283    288  6      
TURN   290    292  3      
STRAND   296    310  15      
STRAND   315    332  18      
TURN   349    352  4      
STRAND   364    366  3      
STRAND   378    381  4      
HELIX   384    387  4      
TURN   400    404  5      
HELIX   406    409  4      
STRAND   410    416  7      
STRAND   422    427  6      
TURN   429    431  3      
TURN   433    437  5      
HELIX   439    444  6      
STRAND   447    452  6      
STRAND   454    460  7      
STRAND   469    475  7      
STRAND   477    479  3      
HELIX   485    488  4      
STRAND   491    497  7      
STRAND   499    501  3      
STRAND   503    508  6      
STRAND   513    520  8      
STRAND   529    536  8      
STRAND   546    556  11      
STRAND   561    565  5      
Sequence information
Length: 2206 AA [This is the length of the unprocessed precursor] Molecular weight: 246051 Da [This is the MW of the unprocessed precursor] CRC64: 537F6A13AD37723B [This is a checksum on the sequence]
        10         20         30         40         50         60 
MGAQVSTQKT GAHENQNVAA NGSTINYTTI NYYKDSASNS ATRQDLSQDP SKFTEPVKDL 

        70         80         90        100        110        120 
MLKTAPALNS PNVEACGYSD RVRQITLGNS TITTQEAANA IVAYGEWPTY INDSEANPVD 

       130        140        150        160        170        180 
APTEPDVSSN RFYTLESVSW KTTSRGWWWK LPDCLKDMGM FGQNMYYHYL GRSGYTIHVQ 

       190        200        210        220        230        240 
CNASKFHQGA LGVFLIPEFV MACNTESKTS YVSYINANPG ERGGEFTNTY NPSNTDVSEG 

       250        260        270        280        290        300 
RQFAALDYLL GSGVLAGNAF VYPHQIINLR TNNSATIVVP YVNSLVIDCM AKHNNWGIVI 

       310        320        330        340        350        360 
LPLAPLAFAA TSSPQVPITV TIAPMCTEFN GLRNITIPVH QGLPTMNTPG SNQFLTSDDF 

       370        380        390        400        410        420 
QSPCALPNFD VTPPIHIPGE VKNMMELAEI DTLIPMNAVD GKVNTMEMYQ IPLNDNLSKA 

       430        440        450        460        470        480 
PIFCLSLSPA SDKRLSHTML GEILNYYTHW TGSIRFTFLF CGSMMATGKL LLSYSPPGAK 

       490        500        510        520        530        540 
PPTNRKDAML GTHIIWDLGL QSSCSMVAPW ISNTVYRRCA RDDFTEGGFI TCFYQTRIVV 

       550        560        570        580        590        600 
PASTPTSMFM LGFVSACPDF SVRLLRDTSH ISQSKLIART QGIEDLIDTA IKNALRVSQP 

       610        620        630        640        650        660 
LRPSQLKQPN GVNSQEVPAL TAVETGASGQ AIPSDVVETR HVINYKTRSE SCLESFFGRA 

       670        680        690        700        710        720 
ACVTILSLTN SSKSGEEKKH FNIWNITYTD TVQLRRKLEF FTYSRFDLEM TFVFTENYPS 

       730        740        750        760        770        780 
TASGEVRNQC DQIMYIPPGA PRPSSWDDYT WQSSSNPSIF YMYGNAPPRM SIPYVGIANA 

       790        800        810        820        830        840 
YSHFYDGFAR VPLEGENTDA GDTFYGLVSI NDFGVLAVRA VNRSNPHTIH TSVRVYMKPK 

       850        860        870        880        890        900 
HIRCWCPRPP RAVLYRGEGV DMISSAIQPL TKVDSITTFG FGHQNKAVYV AGYKICNYHL 

       910        920        930        940        950        960 
ATPSDHLNAI SVLWDRDLMV VESRAQGTDT IARCSCRCGV YYCESRRKYY LVTFTGPTFR 

       970        980        990       1000       1010       1020 
FMEANDYYPA RYQSHMLIGC GFAEPGDCGG ILRCTHGVIG IITAGGEGIV AFADIRDLWV 

      1030       1040       1050       1060       1070       1080 
YEEEAMEQGI TSYIESLGTA FGAGFTHTIS EKVTELTTMV TSTITEKLLK NLVKIVSALV 

      1090       1100       1110       1120       1130       1140 
IVVRNYEDTT TILATLALLG CDISPWQWLK KKACDLLEIP HVMRQGDGWM KKFTEACNAA 

      1150       1160       1170       1180       1190       1200 
KGLRWVSNKI SKFVDWLKCK IIPEAKDKVE FLTKLKQLDM LENQIATIHQ SCPSQEQQEI 

      1210       1220       1230       1240       1250       1260 
LFNNVRWLAV QSRRFAPLYA VEARRISKME STINNYIQFK SKHRIEPVCM LVHGSPGTGK 

      1270       1280       1290       1300       1310       1320 
GIASSLIGRA IAERETTSVY SVPLAPSHFD GYKQQGYDMD DLNQNPDGMD MKLFCQMVST 

      1330       1340       1350       1360       1370       1380 
VEFIPPMASL EEKGILFTSD YVLASTNSHS IAPPTVAHSD ALTRRFAFDV EVYTMSEHSV 

      1390       1400       1410       1420       1430       1440 
KGKLNMATAT QLCKDCPTPA NFKKCCPLVC GKALQLMDRY TRQRFTVDEI TTLIMNEKNR 

      1450       1460       1470       1480       1490       1500 
RANIGNCMEA LFQGPLRYKD LKIDVKTVPP PECISDLLQA VDSQEVRDYC EKKGWIVNVT 

      1510       1520       1530       1540       1550       1560 
SQIQLERNIN RAMTILQAVT TFAAVAGVVY VMYKLFAGQQ GAYTGLPNKK PNVPTIRIAK 

      1570       1580       1590       1600       1610       1620 
VQGPGFDYAV AMAKRNIVTA TTTKGEFTML GVHDNVAILP THAAPGETII VDGKEVEILD 

      1630       1640       1650       1660       1670       1680 
ARALEDQAGT NLEITIITLK RNEKFRDIRP HIPTQITETN DGVLIVNTSK YPNMYVPVGA 

      1690       1700       1710       1720       1730       1740 
VTEQGYLNLS GRQTARTLMY NFPTRAGQCG GIITCTGKVI GMHVGGNGSH GFAAALKRSY 

      1750       1760       1770       1780       1790       1800 
FTQNQGEIQW MRSSKEVGYP IINAPSKTKL EPSAFHYVFE GVKEPAVLTK NDPRLKTDFE 

      1810       1820       1830       1840       1850       1860 
EAIFSKYVGN KITEVDEYMK EAVDHYAGQL MSLDINTEQM CLEDAMYGTD GLEALDLSTS 

      1870       1880       1890       1900       1910       1920 
AGYPYVAMGK KKRDILDKQT RDTKEMQRLL DTYGINLPLV TYVKDELRSK TKVEQGKSRL 

      1930       1940       1950       1960       1970       1980 
IEASSLNDSV AMRMAFGNLY AAFHKNPGVV TGSAVGCDPD LFWSKIPVLM EEKLFAFDYT 

      1990       2000       2010       2020       2030       2040 
GYDASLSPAW FEALKMVLEK IGFGNRVDYI DYLNHSHHLY KNKTYCVKGG MPSGCSGTSI 

      2050       2060       2070       2080       2090       2100 
FNSMINNLII RTLLLRTYKG IDLDHLKMIA YGDDVIASYP HEVDASLLAQ SGKDYGLTMT 

      2110       2120